Access to healthcare resources significantly impacts the variability in cancer treatment. Patients in well-resourced healthcare systems may have access to the latest diagnostic tools, cutting-edge treatments, and clinical trials. In contrast, those in under-resourced areas may only have access to standard treatments, which can affect outcomes. Efforts to improve healthcare access, such as telemedicine and global health initiatives, aim to reduce these disparities.
